DK1313504T3 - Fremgangsmåder og sammensætninger til hæmning af angiogenese - Google Patents

Fremgangsmåder og sammensætninger til hæmning af angiogenese

Info

Publication number
DK1313504T3
DK1313504T3 DK01968398T DK01968398T DK1313504T3 DK 1313504 T3 DK1313504 T3 DK 1313504T3 DK 01968398 T DK01968398 T DK 01968398T DK 01968398 T DK01968398 T DK 01968398T DK 1313504 T3 DK1313504 T3 DK 1313504T3
Authority
DK
Denmark
Prior art keywords
methods
compounds
inhibiting angiogenesis
compositions
endothelial cells
Prior art date
Application number
DK01968398T
Other languages
English (en)
Inventor
Mahesh C Sharma
George P Tuszynski
Original Assignee
Philadelphia Health & Educatio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Health & Educatio filed Critical Philadelphia Health & Educatio
Application granted granted Critical
Publication of DK1313504T3 publication Critical patent/DK1313504T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01968398T 2000-09-01 2001-09-04 Fremgangsmåder og sammensætninger til hæmning af angiogenese DK1313504T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22966700P 2000-09-01 2000-09-01
US27720401P 2001-03-20 2001-03-20
PCT/US2001/027310 WO2002017857A2 (en) 2000-09-01 2001-09-04 Methods and compositions for inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
DK1313504T3 true DK1313504T3 (da) 2007-02-26

Family

ID=26923501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01968398T DK1313504T3 (da) 2000-09-01 2001-09-04 Fremgangsmåder og sammensætninger til hæmning af angiogenese

Country Status (9)

Country Link
EP (1) EP1313504B1 (da)
JP (1) JP2004507482A (da)
AT (1) ATE346607T1 (da)
AU (1) AU2001288648A1 (da)
CA (1) CA2421503A1 (da)
DE (1) DE60124927T2 (da)
DK (1) DK1313504T3 (da)
ES (1) ES2272537T3 (da)
WO (1) WO2002017857A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE401337T1 (de) 2000-11-28 2008-08-15 David M Waisman Antiangiogene polypeptide
CA2514873C (en) 2002-12-13 2012-01-03 David Waisman Compositions and methods for inhibiting tumor growth and metastasis
EP1670510A1 (en) * 2003-09-24 2006-06-21 Peter Krammer Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis.
DE102004046540A1 (de) * 2004-09-21 2006-04-06 Eberhard-Karls-Universität Tübingen Universitätsklinikum Annexin-Modulation und Infektionsresistenz
US20060111423A1 (en) * 2004-10-26 2006-05-25 Zeligs Michael A Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus-associated disease
US9555074B2 (en) 2010-10-08 2017-01-31 Regents Of The University Of Minnesota Annexin II compositions
DK3068428T3 (da) 2013-11-13 2022-10-17 Univ Minnesota Annexin-ii-variant-sammensætninger og fremgangsmåder
EP3045470A1 (en) 2015-01-15 2016-07-20 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy
PT3468621T (pt) 2016-06-10 2022-12-21 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts O domínio central das anexinas e suas utilizações no fornecimento e vacinação de antigénios

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051364A (en) * 1989-02-16 1991-09-24 The Salk Institute For Biological Studies Anti-lipocortin-I and anti-lipocortin-II monoclonal antibodies
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
EP1064378A2 (en) * 1998-03-27 2001-01-03 The Board Of Trustees Of The Leland Stanford Junior University Hypoxia-inducible human genes, proteins, and uses thereof
CZ302303B6 (cs) * 1998-08-25 2011-02-16 Merck Patent Gmbh Homodimerní fúzní protein vykazující inhibicní aktivitu na angiogenezi, zpusob jeho produkce, molekula DNA a replikovatelný expresní vektor

Also Published As

Publication number Publication date
JP2004507482A (ja) 2004-03-11
CA2421503A1 (en) 2002-03-07
EP1313504A2 (en) 2003-05-28
EP1313504A4 (en) 2004-06-30
ATE346607T1 (de) 2006-12-15
WO2002017857A3 (en) 2002-06-13
DE60124927D1 (de) 2007-01-11
WO2002017857A2 (en) 2002-03-07
AU2001288648A1 (en) 2002-03-13
ES2272537T3 (es) 2007-05-01
DE60124927T2 (de) 2007-09-20
EP1313504B1 (en) 2006-11-29

Similar Documents

Publication Publication Date Title
DE60142921D1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
NI200600319A (es) Antagonistas de ccr2 de sal cuaternaria
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
PT1187918E (pt) Antagonistas de tek
DK1353672T3 (da) Syntese af 4-amino-thalidomidenantiomerer
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
DK1325011T3 (da) Fremgangsmåder og forbindelser til behandling af proliferative sygdomme
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
ATE273699T1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DK1250152T3 (da) Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DK1017684T3 (da) Kontrastmiddel til afbildning af infarkter og nekroser
DK1313504T3 (da) Fremgangsmåder og sammensætninger til hæmning af angiogenese
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
DK1268472T3 (da) 3-aminopyrazolinhibitorer af cyclinafhængige kinaser
SE9801494D0 (sv) Novel use
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
UY26265A1 (es) Compuestos calciolíticos
DK1185293T3 (da) IL6RIL6-kimær til behandling af neurodegenerative sygdomme
DK1468996T3 (da) Indolderivater til behandling af CNS-sygdomme
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme